The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines.
Norah S AlsubaieShahad M Al RammahReema A AlshouimiMohammed Y AlzahraniMajed S Al YamiAbdulaali R AlmutairiOsamah M AlfayezGhazwa B KorayemOmar A AlmohammedPublished in: Thrombosis journal (2021)
The DOACs are associated with a lower risk of symptomatic VTE and VTE recurrence, but the risk of bleeding remains a considerable concern. Clinical decisions should be made by assessing individual patient's risk of VTE and bleeding.